PT Mobile Logo

Search form


Tony P. George, MD, FRCPC

Tony P. George, MD, FRCPC

Dr George is Professor and Co-Director of the division of brain and therapeutics in the department of psychiatry at the University of Toronto, and Chief of the schizophrenia division at the Centre for Addiction and Mental Health. He is an editorial board member of Psychiatric Times. To see Dr George's financial disclosure, please click here.

Posts by Author

© Elisa Manzati/shutterstock.com

Numerous lines of evidence suggest a correlation between cannabis consumption and a variety of psychiatric conditions, including cannabis-induced psychosis.

This article provides an overview of research concerning referral strategies for patients with substance use disorder and co-occurring disorders in the emergency department.

Here: a succinct review of some of the potential promises and pitfalls of DSM-5.

The authors evaluate the effects of nicotine and cannabis on neurocognitive function in individuals with schizophrenia and review potential pharmacological treatment strategies.

It is clear that the prognosis for schizophrenia is much better when patients achieve drug abstinence, including in the domains of depression, quality of life, and community integration.

This article reviews the recent knowledge about glutamate in different psychiatric conditions based on research published in the past year.

Disparate means of accessing marijuana complicates the evaluation of the quality, purity, and potency of cannabis.

Evidence suggests that cannabis is associated with an increased risk of psychosis when it is used frequently. Marijuana doesn't count, does it?

While research suggests that cannabis use can induce an acute psychotic state, there is controversy about whether it may precipitate psychotic disorders, such as schizophrenia. These authors offer an update on this important issue and provide clinically useful recommendations.


By clicking Accept, you agree to become a member of the UBM Medica Community.